Nav: Home

Gene-Toxin Link May Shed Light On Cause Of Parkinson's Disease

July 31, 1998

COLUMBUS, Ohio -- Researchers seeking a cause for dementia in patients with Parkinson's disease have discovered that the combination of a defective gene and exposure to pesticides may increase a person's risk for developing the dementia.

A study found that a group of Parkinson's patients whohad a particular mutant gene, or allele, and who were exposedto pesticides in the past, were three times more likely to develop dementia than Parkinson's patients who lacked the two factors. About one out of every five Parkinson's patients develops dementia.

"The gene alone, coupled with environmental exposure, turned out to be a potent risk factor for Parkinson's with dementia in a group of patients with the disease," said Jean Hubble, clinical associate professor of neurology at Ohio State University.

According to the study, published in a recent issue of Neuroepidemiology, potential risks for developing Parkinson's disease with dementia (PD+D) include pesticide exposure and at least one defective copy of a gene called CYP 2D6 29B+. This gene activates a series of enzymes in the liver that metabolize and detoxify chemicals that get into the body.

Parkinson's disease is a muscular disorder that causes a person to lose control of coordination. It also causes tremors, poor balance, slowness and stooped posture. These symptoms are more severe in people with PD+D.

The researchers studied 43 patients with PD+D and 51 with Parkinson's disease but who did not have dementia. They analyzed three genes suspected of playing a role in predisposing a person to the disease. They also considered three other characteristics shown to be more common among Parkinson's patients with dementia: Having less than 12 years of formal education, the onset of symptoms after age 60 and greater motor impairment. The researchers also considered substantial pesticide exposure and family history of the disease.

"There was a hint that chemical exposures might be important where dementia is concerned," Hubble said, noting that past research has shown pesticide exposure to be a risk factor for Parkinson's disease.

Researchers paired the three suspect genes with each other and with pesticide exposure. Only the mutant CYP gene-pesticide exposure combination emerged as a significant risk factor for dementia in Parkinson's.

In the 43 patients with PD+D, 12 percent had both the defective gene and a history of pesticide exposure while 2 percent of the same group had neither factor. The study defined exposure to pesticides as 20 or more days in any given year. Hubble said the 20-day exposure is based on typical use of chemicals in commercial farming. But it's unclear if pesticides are a direct cause of PD+D.

"Pesticides may be perfectly safe for 90 percent of the U.S. population because most people can readily detoxify these chemicals," Hubble said. "Perhaps there's a small percentage of individuals who cannot handle or detoxify chemical compounds because of their mutant CYP allele or other genetic factors."

She said the results of the study should be interpreted with caution.

"Our study does not show that pesticide exposure is the cause of dementia in Parkinson's disease," Hubble said. "All we've shown is that these two factors together appear to raise the relative risk of developing dementia in Parkinson's disease."

Hubble conducted the study with researchers from the University of Kansas Medical Center, the Barrow Neurological Institute in Phoenix and the Geriatric Research Education and Clinical Center in Seattle.

The study was funded with grants from the National Institute on Aging and the Parkinson's Disease Research Fund at the Barrow Neurological Institute.
Written by Holly Wagner, (614)292-8310;

Ohio State University

Related Dementia Articles:

Digital solutions for dementia care
Telehealth delivery of dementia care in the home can be as effective as face-to-face home visit services if carers and recipients take advantage of the technologies available, Australian researchers say.
Despite a marked reduction in the prevalence of dementia, the number of people with dementia is set to double by 2050 according to new Alzheimer Europe report
Today, at a European Parliament lunch debate, Alzheimer Europe launched a new report presenting the findings of its collaborative analysis of recent prevalence studies and setting out updated prevalence rates for dementia in Europe.
Inflammatory marker linked to dementia
Higher levels of an inflammatory marker, sCD14, were associated with brain atrophy, cognitive decline and dementia in two large heart studies.
How likely do you think you are to develop dementia?
A poll suggests almost half of adults ages 50 to 64 believe they're likely to develop dementia.
Latest issue of Alzheimer's & Dementia
Predicting heart disease might also be a warning sign for Alzheimer's; A new way to think about the environment and Alzheimer's research; Most dementia patients don't receive care from physicians who specialize in brain health.
What multilingual nuns can tell us about dementia
A strong ability in languages may help reduce the risk of developing dementia, says a new University of Waterloo study.
Brain changes may help track dementia, even before diagnosis
Even before a dementia diagnosis, people with mild cognitive impairment may have different changes in the brain depending on what type of dementia they have, according to a study published in the September 11, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Could marriage stave off dementia?
Dementia and marital status could be linked, according to a new Michigan State University study that found married people are less likely to experience dementia as they age.
Migraine diagnoses positively associated with all-cause dementia
Several studies have recently focused on the association between migraine headaches and other headaches and dementia and found a positive migraine-dementia relationship.
Apathy: The forgotten symptom of dementia
Apathy is the most common neuropsychiatric symptom of dementia, with a bigger impact on function than memory loss -- yet it is under-researched and often forgotten in care.
More Dementia News and Dementia Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Clint Smith
The killing of George Floyd by a police officer has sparked massive protests nationwide. This hour, writer and scholar Clint Smith reflects on this moment, through conversation, letters, and poetry.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at